Biologic Therapeutic Drugs: Technologies and Global Markets

Table of Contents

Chapter 1 Introduction

Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Biopharmaceutical Industry Structure
Origins of Biotechnology
Involvement of Large Pharmaceutical Companies
Overview of Biologics
Biologics Manufacturing
Biopharmaceutical Manufacturing Process

• The Preparation Process
• Expression Systems for Therapeutic Protein Production
• E. coli Advantages for Microbial Production
• Mammalian Cell Therapeutic Protein Production

FDA Regulation of Biologics

Chapter 4 Impact of COVID-19 Pandemic

Introduction
Short-Term Impact
Long-Term Impact

• Delayed Approvals for Non-COVID-Related Pharmaceutical Products
• Self-Sufficiency in Pharma Industry

Progression of COVID-19
Government Expenditures on COVID-19
Social Impact of COVID-19
Impact on Insurance Providers
Impact on Health Technology Assessment

• Changes in Consumption Trends in Health-Related Products

Chapter 5 Market Dynamics

Market Drivers

• Overview
• Rising Prevalence of Chronic Diseases
• Advancement in Biologics
• Growing Geriatric Population

Market Restraints

• Emergence of Biosimilars

Market Opportunities

• Opportunities in Emerging Nations

Chapter 6 Market Breakdown by Product Segment

Global Market for Biologic Therapeutic Drugs by Product Segment

• Therapeutic Proteins
• Vaccines
• Others

Chapter 7 Market Breakdown by Region

Global Market for Biologic Therapeutic Drugs by Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Chapter 8 Competitive Landscape

Porter's Five Forces Analysis

• Bargaining Power of Suppliers
• Bargaining Power of Buyers
• Threat of New Entrants
• Threat of Substitutes
• Competitive Rivalry/Degree of Competition

Chapter 9 Company Profiles

AMGEN INC.
BAXTER
CHINA BIOLOGIC PRODUCTS INC.
CSL LTD.
DENDREON PHARMACEUTICALS LLC
ELI LILLY AND CO.
F. HOFFMANN-LA ROCHE LTD.
GLAXOSMITHKLINE PLC
GLYCOTOPE GMBH
GRIFOLS S.A.
JSC PHARMSTANDARD
KEDRION S.P.A.
NOVARTIS AG
OCTAPHARMA AG
RELIANCE LIFE SCIENCES
SANOFI
TEVA PHARMACEUTICAL INDUSTRIES LTD.

List of Tables

Summary Table : Global Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 1 : Biologic Orphan Drugs, by Trade Name and Indication
Table 2 : Expenditures on COVID-19 Crisis, by Selected Country
Table 3 : Interim Economic Outlook Forecasts, by Country/Region, 2019-2021
Table 4 : Number and Distribution of Persons Aged 60 and Over, by Region, 2017 and 2050
Table 5 : Global Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 6 : Global Market for Biologic Therapeutic Proteins, by Region, Through 2025
Table 7 : Global Market for Biologics Therapeutic Vaccines, by Region, Through 2025
Table 8 : Global Market for Other Biologic Therapeutic Drug Products, by Region, Through 2025
Table 9 : Global Market for Biologic Therapeutic Drugs, by Region, Through 2025
Table 10 : North American Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 11 : North American Market for Biologic Therapeutic Drugs, by Country, Through 2025
Table 12 : European Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 13 : European Market for Biologic Therapeutic Drugs, by Country, Through 2025
Table 14 : Asia-Pacific Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 15 : Asia-Pacific Market for Biologic Therapeutic Drugs, by Country, Through 2025
Table 16 : Japanese Market Statistics
Table 17 : Latin American Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 18 : Middle Eastern and African Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 19 : Porter's Five Forces Analysis
Table 20 : Amgen Inc.: Product Portfolio
Table 21 : Baxter: Product Portfolio
Table 22 : Baxter: Recent Developments, 2021
Table 23 : China Biologic Products Holdings Inc.: Product Portfolio
Table 24 : China Biologic Products Holdings Inc.: Pipeline Plasma Products
Table 25 : China Biologic Products Holdings Inc.: Recent Developments, 2017
Table 26 : CSL Ltd.: Products Portfolio
Table 27 : CSL Ltd.: Recent Developments, 2021
Table 28 : Dendreon Pharmaceuticals LLC: Product Portfolio
Table 29 : Eli Lilly and Co.: Product Portfolio
Table 30 : F. Hoffmann-La Roche Ltd.: Financials, 2019
Table 31 : F. Hoffmann-La Roche Ltd.: Revenues, by Business Segment, 2016-2018
Table 32 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 33 : GlaxoSmithKline Plc: Financials, 2017-2019
Table 34 : GlaxoSmithKline Plc: Products and Services
Table 35 : Glycotope GmbH: Product Portfolio
Table 36 : Grifols S.A.: Product Portfolio
Table 37 : Grifols S.A.: Recent Developments, 2020
Table 38 : JSC Pharmstandard: Product Portfolio
Table 39 : Kedrion S.p.A.: Products and Services
Table 40 : Kedrion S.p.A.: Developments and Strategies
Table 41 : Novartis AG: Product Portfolio
Table 42 : Octapharma AG: Products and Services
Table 43 : Octapharma AG: Recent Developments, 2020
Table 44 : Reliance Life Sciences: Product Portfolio
Table 45 : Sanofi: Products and Services
Table 46 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 47 : Teva Pharmaceutical Industries Ltd.: Financials, 2017-2019

List of Figures

Summary Figure : Global Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 1 : Impact of COVID-19 on the Pharmaceutical Industry
Figure 2 : Comparison of GDP Growth, by Country, 2019 and 2020
Figure 3 : Global Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 4 : Global Market for Biologic Therapeutic Proteins, 2018-2025
Figure 5 : Global Market for Biologic Therapeutic Proteins, by Region, 2018-2025
Figure 6 : Global Market for Biologics Therapeutic Vaccines, 2018-2025
Figure 7 : Global Market for Biologics Therapeutic Vaccines, by Region, 2018-2025
Figure 8 : Global Market for Other Biologic Therapeutic Drug Products, 2018-2025
Figure 9 : Global Market for Other Biologic Therapeutic Drug Products, by Region, 2018-2025
Figure 10 : Global Market for Biologic Therapeutic Drugs, by Region, 2018-2025
Figure 11 : Global Market Shares of Biologic Therapeutic Drugs, by Region, 2019
Figure 12 : North American Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 13 : North American Market Shares of Biologic Therapeutic Drugs, by Country, 2019
Figure 14 : U.S. Market for Biologic Therapeutic Drugs, 2018-2025
Figure 15 : Canadian Market for Biologic Therapeutic Drugs, 2018-2025
Figure 16 : European Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 17 : European Market Shares of Biologic Therapeutic Drugs, by Country, 2019
Figure 18 : German Market for Biologic Therapeutic Drugs, 2018-2025
Figure 19 : U.K. Market for Biologic Therapeutic Drugs, 2018-2025
Figure 20 : French Market for Biologic Therapeutic Drugs, 2018-2025
Figure 21 : Italian Market for Biologic Therapeutic Drugs, 2018-2025
Figure 22 : Spanish Market for Biologic Therapeutic Drugs, 2018-2025
Figure 23 : Rest of European Market for Biologic Therapeutic Drugs, 2018-2025
Figure 24 : Asia-Pacific Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 25 : Asia-Pacific Market Shares of Biologic Therapeutic Drugs, by Country, 2019
Figure 26 : Chinese Market for Biologic Therapeutic Drugs, 2018-2025
Figure 27 : Japanese Market for Biologic Therapeutic Drugs, 2018-2025
Figure 28 : Indian Market for Biologic Therapeutic Drugs, 2018-2025
Figure 29 : Rest of Asia-Pacific Market for Biologic Therapeutic Drugs, 2018-2025
Figure 30 : Latin American Market for Biologic Therapeutic Drugs, 2018-2025
Figure 31 : Latin American Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 32 : Middle Eastern and African Market for Biologic Therapeutic Drugs, 2018-2025
Figure 33 : Middle Eastern and African Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 34 : Amgen Inc.: Annual Revenue, 2015-2019
Figure 35 : Amgen Inc.: Revenue Share, by Country, 2019
Figure 36 : Baxter: Annual Revenue, 2015-2019
Figure 37 : Baxter: Revenue Share, by Business Unit, 2019
Figure 38 : Baxter: Revenue Share, by Region, 2019
Figure 39 : China Biologic Products Holdings Inc.: Financials, 2015-2019
Figure 40 : China Biologic Products Holdings Inc.: Revenue Share, by Segment, 2019
Figure 41 : CSL Ltd.: Financials, 2015-2019
Figure 42 : CSL Ltd.: Revenue Share, by Segment, 2019
Figure 43 : CSL Ltd.: Revenue Share, by Country/Region, 2019
Figure 44 : Eli Lilly and Co.: Annual Revenue, 2017-2019
Figure 45 : Eli Lilly and Co.: Revenue Share, by Region, 2019
Figure 46 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Segment, 2019
Figure 47 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, 2019
Figure 48 : GlaxoSmithKline Plc: Revenue Share, by Business Segment, 2019
Figure 49 : GlaxoSmithKline Plc: Revenue Share, by Region, 2019
Figure 50 : Grifols S.A.: Financials, 2015-2019
Figure 51 : Grifols S.A.: Revenues Share, by Segment, 2019
Figure 52 : Grifols S.A.: Revenue Share, by Region, 2019
Figure 53 : Kedrion S.p.A.: Financials, 2015-2019
Figure 54 : Kedrion S.p.A.: Revenue Share, by Segment, 2019
Figure 55 : Kedrion S.p.A.: Revenue Share, by Region, 2019
Figure 56 : Novartis AG.: Annual Revenue, 2015-2019
Figure 57 : Novartis AG: Revenue Share, by Region, 2019
Figure 58 : Novartis AG: Revenue Share, by Business Segment, 2019
Figure 59 : Octapharma AG: Financials, 2015-2019
Figure 60 : Octapharma AG: Revenue, by Operating Income, 2015-2019
Figure 61 : Sanofi: Annual Revenue, 2017-2019
Figure 62 : Sanofi: Revenue Share, by Business Segment, 2019
Figure 63 : Sanofi: Revenue Share, by Region, 2019
Figure 64 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Region, 2019

当レポートのプレスリリースは発行されておりません。